Literature DB >> 11883934

Alternative splicing modulates subcellular localization of laforin.

Subramaniam Ganesh1, Toshimitsu Suzuki, Kazuhiro Yamakawa.   

Abstract

Laforin is a dual-specificity phosphatase coded by the EPM2A gene defective in Lafora's progressive myoclonus epilepsy. We reported earlier that laforin is a cytoplasmic protein associated primarily with polyribosome. In the present study we characterized the expression of an EPM2A splice variant, named C-terISO, originating from the usage of a novel exon located in the 3'-untranslated region of exon 4 and encoding a laforin isoform containing unique sequences at its carboxyl terminus. Transfection studies demonstrate that, in addition to cytoplasm, the protein coded by C-terISO was targeted to the nucleus, a distinctive feature that was not observed for laforin coded by the major transcript of the EPM2A gene. The unique C-terminal sequence did not affect laforin's affinity for polysome, but sequestered nearly an equal amount of the protein into the nucleus. Our results are significant in light of the finding that laforin is an active phosphatase; therefore, isoforms targeted to different cellular compartments might dephosphorylate and regulate distinct cellular substrates. (C)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883934     DOI: 10.1006/bbrc.2002.6590

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  ACBD2/ECI2-Mediated Peroxisome-Mitochondria Interactions in Leydig Cell Steroid Biosynthesis.

Authors:  Jinjiang Fan; Xinlu Li; Leeyah Issop; Martine Culty; Vassilios Papadopoulos
Journal:  Mol Endocrinol       Date:  2016-05-11

Review 2.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

3.  A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.

Authors:  Alan Cheng; Mei Zhang; Matthew S Gentry; Carolyn A Worby; Jack E Dixon; Alan R Saltiel
Journal:  Genes Dev       Date:  2007-10-01       Impact factor: 11.361

4.  Late-onset Lafora disease with prominent parkinsonism due to a rare mutation in EPM2A.

Authors:  David S Lynch; Nicholas W Wood; Henry Houlden
Journal:  Neurol Genet       Date:  2016-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.